ADVERTISEMENT

Canada

Bausch + Lomb Results Enhance Acquisition Image

Bausch + Lomb Results Enhance Acquisition Image

Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.

US Nutrition Market Business News: Boka Well, Beachbody/HSAs, Dr Pepper/Ghost, More

US Nutrition Market Business News: Boka Well, Beachbody/HSAs, Dr Pepper/Ghost, More

Beachbody offers supplement sales using health savings accounts; PlantX, Boka launches oral health supplements; supplements take Form from RTE meal provider Factor; LIV3 JV behind marketing SugarShield; Ghost among Keurig Dr Pepper brands; and Nutra-Med Packaging expands with Legacy Pharma.

PharmaTher’s Ketamine Formulation Receives CRL From FDA

PharmaTher’s Ketamine Formulation Receives CRL From FDA

After sharing multiple updates to the regulatory status of its ketamine formulation, PharmaTher received a complete response letter from the FDA, which required minor information and clarifications from the company.

Fresenius Offers First And Only Canadian Tocilizumab Biosimilar

Fresenius Offers First And Only Canadian Tocilizumab Biosimilar

Fresenius Kabi has claimed another first for its Tyenne biosimilar rival to Actemra, becoming the debut challenger to the rheumatoid arthritis treatment to launch in Canada.

US Q3 Consumer Health Earnings Preview: B+L’s Independence Has Private Equity Interest

US Q3 Consumer Health Earnings Preview: B+L’s Independence Has Private Equity Interest

Kenvue may have to start sharing time with Bausch + Lomb in investors’ discussions about the outlook for success at US consumer health firms separated from former parent firms as they and their competitors begin reporting the results for their latest quarters.

Fusion CEO Talks AZ Deal Making And Canada’s Blossoming Biotech Ecosystem

Fusion CEO Talks AZ Deal Making And Canada’s Blossoming Biotech Ecosystem

Fusion Pharmaceuticals Inc CEO John Valliant talked to In Vivo about Canadian leadership in radiopharmaceutical innovation, its differentiated approach, and excitement around combination therapies for precision cancer treatments.

Global Pharma Guidance Tracker – September 2024

Global Pharma Guidance Tracker – September 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Lupin Signs ADHD Drugs Deal With Aytu In Canada

Lupin Signs ADHD Drugs Deal With Aytu In Canada

Lupin has added two ADHD drugs to its Canadian portfolio, while also signing multiple branded deals in other global markets.

Country Life Vitamins Surveys Consumers About Healthy Aging For Ageless Theory Line Launch

Country Life Vitamins Surveys Consumers About Healthy Aging For Ageless Theory Line Launch

Country Life Vitamins launches healthy aging support line as it announces less than half of US consumers in a recent survey were aware of biological processes that affect aging. Groupe Berken and Arctic Biosciences partner to bring to North America herring caviar oil extract in a supplement designed to support optimal health across all life stages.

OcuSoft Retains Retaine Brand Name, Looks Askance At Eyeleve Marketer’s Reference

OcuSoft Retains Retaine Brand Name, Looks Askance At Eyeleve Marketer’s Reference

After launching Retaine MGD Advanced, OcuSoft says a release by Bruder Healthcare referenced Retaine MGD trademark and statements from a previous OcuSoft announcement about the original product attributed to an optometrist. B+L, Rohto brand and homeopathic firm Relief Products also make US OTC eye care space moves.